بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant rates » significant facies (توسيع البحث), significant role (توسيع البحث), significant risks (توسيع البحث)
rates decrease » rate decreased (توسيع البحث), greatest decrease (توسيع البحث), greater decrease (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant rates » significant facies (توسيع البحث), significant role (توسيع البحث), significant risks (توسيع البحث)
rates decrease » rate decreased (توسيع البحث), greatest decrease (توسيع البحث), greater decrease (توسيع البحث)
-
1161
-
1162
-
1163
The age-specific incidence rates of NPC and ENKTL across different time-periods.
منشور في 2024الموضوعات: -
1164
Comparison of eye drop instillation success rates across different age groups.
منشور في 2025الموضوعات: -
1165
Study Data.
منشور في 2025"…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"
-
1166
Study outcomes.
منشور في 2025"…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"
-
1167
Patient characteristics.
منشور في 2025"…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"
-
1168
-
1169
Expression and diagnostic value of the 8 hub genes in the GSE190635 validation dataset.
منشور في 2025الموضوعات: -
1170
-
1171
-
1172
-
1173
-
1174
-
1175
-
1176
-
1177
-
1178
-
1179
-
1180
This is an additional table reporting supplementary data about external injury scores.
منشور في 2025الموضوعات: